Detalles de la búsqueda
1.
Predicting Inflammatory Arthritis in At-Risk Persons: Development of Scores for Risk Stratification.
Ann Intern Med
; 176(8): 1027-1036, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37523695
2.
Ultrasound in anti-CCP+ at-risk individuals without clinical synovitis: development of a novel 6-joint protocol for feasible risk prediction.
Rheumatology (Oxford)
; 2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37934127
3.
Ultrasound subclinical synovitis in anti-CCP-positive at-risk individuals with musculoskeletal symptoms: an important and predictable stage in the rheumatoid arthritis continuum.
Rheumatology (Oxford)
; 61(8): 3192-3200, 2022 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34849610
4.
Real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway.
Rheumatology (Oxford)
; 60(9): 4048-4054, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33331938
5.
In anti-CCP+ at-risk individuals, radiographic bone erosions are uncommon and are not associated with the development of clinical arthritis.
Rheumatology (Oxford)
; 60(7): 3156-3164, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33415335
6.
Ultrasound erosions in the feet best predict progression to inflammatory arthritis in anti-CCP positive at-risk individuals without clinical synovitis.
Ann Rheum Dis
; 79(7): 901-907, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32366522
7.
MRI inflammation of the hand interosseous tendons occurs in anti-CCP-positive at-risk individuals and may precede the development of clinical synovitis.
Ann Rheum Dis
; 78(6): 781-786, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30904831
8.
Enriching case selection for imminent RA: the use of anti-CCP antibodies in individuals with new non-specific musculoskeletal symptoms - a cohort study.
Ann Rheum Dis
; 75(8): 1452-6, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26395501
9.
Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study.
Rheumatology (Oxford)
; 55(12): 2181-2190, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27638812
10.
First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis.
Ann Rheum Dis
; 78(8): 1138-1140, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30852551
11.
Factors associated with resolution of ultrasound subclinical synovitis in anti-CCP-positive individuals with musculoskeletal symptoms: a UK prospective cohort study.
Lancet Rheumatol
; 6(2): e72-e80, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38267105
12.
Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test.
RMD Open
; 10(2)2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38599655
13.
Poly-Refractory Rheumatoid Arthritis: An Uncommon Subset of Difficult to Treat Disease With Distinct Inflammatory and Noninflammatory Phenotypes.
Arthritis Rheumatol
; 76(4): 510-521, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38059326
14.
Single-centre experience of refractory rheumatoid arthritis.
Rheumatol Adv Pract
; 6(2): rkac057, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35937776
15.
Prioritising referrals of individuals at-risk of RA: guidance based on results of a 10-year national primary care observational study.
Arthritis Res Ther
; 24(1): 26, 2022 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35042555
16.
Third-Generation Anti-Cyclic Citrullinated Peptide Antibodies Improve Prediction of Clinical Arthritis in Individuals at Risk of Rheumatoid Arthritis.
Arthritis Rheumatol
; 72(11): 1820-1828, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32840033
Resultados
1 -
16
de 16
1
Próxima >
>>